ClinicalTrials.gg
CompletedNCT05261607Updated Sep 22, 2026

Analysis of the Evolution of Mortality in an Intensive Care Unit

An observational study in Intensive Care Unit, Mortality and Epidemiology, sponsored by Hospital Universitario Getafe. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Hospital Universitario Getafe · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
27,463
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 11 studies in Systemic Inflammatory Response Syndrome with a site in Spain — 2 open to participants now, 2 under way, none of them phase 3. Systemic Inflammatory Response Syndrome · Spain.

Started
1991
the only one that year
Observational
4 of 11
none open now
Registered
9th of 11
by date
Lead sponsor
1 of 11
Hospital Universitario Getafe

Among the 11 studies in Systemic Inflammatory Response Syndrome with a site in Spain, this one is the only one that started in 1991, is one of 4 observational ones, and was the 9th registered.

Systemic Inflammatory Response Syndrome

195 studies on the registry are indexed under Systemic Inflammatory Response Syndrome; 24 are open to participants now.

Browse Systemic Inflammatory Response Syndrome studies →

Open to participants now

2 of the 11 studies in Systemic Inflammatory Response Syndrome with a site in Spain are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 20 Systemic Inflammatory Response Syndrome studies recruiting now, 13 (65%) set no upper age limit and 4 (20%) stop at 75 or younger; 5 take children under 18; none take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Systemic Inflammatory Response Syndrome with a site in Spain, or all of them as a file.
02

Study summary

The intensive care units is of the main components of modern healthcare systems. Formally, its aim is to offer the critically ill health care fit to their needs; ensuring that this health care is appropriate, sustainable, ethical and respectful of their autonomy. Intensive medicine is a cross-sectional specialty that encompasses a broad spectrum of pathologies in their most severe condition, and specifically has as its foundation the practice of comprehensive care of the patient with organ dysfunction and susceptible to recovery. Although critically ill patients are a heterogeneous population, they have in common the need for a high level of care, often requiring the use of high technology, specific procedures for the support of organ dysfunction and the collaboration of other medical and surgical specialties for their management and treatment.

Since their origins in the late 1950s, intensive care units have been adapting to the changes arising from the best scientific evidence. In the late 1990s and early 2000s, there were some successful clinical trials published that had tested alternative management strategies in the ICU.

Mechanical ventilation is an intervention that defines the critical care specialty. Between 1970 and the 1990s, the management focused on normalizing arterial blood gas with aggressive mechanical ventilation. Over the ensuing decades, it became apparent that performing positive pressure ventilation worsened lung injury. The pivotal moment in the mechanical ventilation story would be the low versus high tidal volume trial. This trial shifted the focus away from normalizing gas exchange to reducing harm with mechanical ventilation. Further, it paved way for further trials testing ventilation interventions (PEEP strategy, prone position ventilation) and nonventilation interventions (neuromuscular blockade, corticosteroids, inhaled nitric oxide, extracorporeal gas exchange) in critically ill patients.

That evidence-based intensive care medicine has undoubtedly had an influence on the outcome of critically ill patients, in general, and, particularly, of patients requiring mechanical ventilation. Temporal changes in mortality over the time have been scarcely reported for patients admitted to intensive care unit.

Objective of this study is to estimate the changes over the time in several outcomes in the patients admitted to an 18-beds medical-surgical intensive care unit from 1991 (year of start of activity) to 2026

03

Conditions studied

  • Intensive Care Unit
  • Mortality
  • Epidemiology
  • Respiration, Artificial
  • Sepsis Syndrome
  • Respiratory Failure
  • Neurologic Disorder

Keywords

  • Intensive care units
  • Outcome
  • Mortality
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who required a admission to intensive care unit

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to intensive care unit

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
27,463 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Intensive Care Unit Mortality

    Died during stay in the intensive care unit

    Time frame: 180 days

Secondary outcomes

  1. Hospital Mortality

    Died during stay in the hospital

    Time frame: 180 days

  2. Mortality 28-day

    Mortality at day 28 after admission in the Hospital

    Time frame: 28 days from date of admission in the Hospital

  3. Use of Mechanical ventilation

    Proportion of patients who required mechanical ventilation (invasive and non-invasive) during stay in the intensive care unit

    Time frame: 180 days

  4. Length of stay in the intensive care unit

    Stay in the intensive care unit

    Time frame: 180 days

  5. Length of stay in the hospital

    Stay in the hospital

    Time frame: 180 days

  6. Complications/events during stay in the intensive care unit

    Rate of complications/events occurred in the intensive care unit

    Time frame: 180 days

07

Study locations

1 site
  • Hospital Universitario de Getafe
    Getafe, Madrid 28905, Spain
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 1991 to primary completion in Jul 2026, 420 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2022
First posted
Mar 2, 2022
StartActual
Jul 16, 1991
Primary completionActual
Jul 16, 2026
CompletionActual
Jul 31, 2026
Last update
Sep 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05261607
Lead sponsor
Hospital Universitario Getafe
Responsible party
Fernando Frutos-Vivar (Principal Investigator, Hospital Universitario Getafe) — Principal investigator
First posted
Mar 2, 2022
Start date
Jul 16, 1991
Primary completion
Jul 16, 2026
Completion
Jul 31, 2026
Last update
Sep 22, 2026

Study contacts

Fernando Frutos-Vivar, MD
principal investigator · Hospital Universitario de Getafe

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion